TB relapse
Showing 1 - 25 of 4,666
The INSTITUT Study
Recruiting
- Tuberculosis, Pulmonary
- Undernutrition
- Nutritional support
-
Porto-Novo, Benin
- +1 more
Oct 12, 2023
Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)
Not yet recruiting
- Tuberculosis
- Human Immunodeficiency Virus
- Optimised rifamycin
- (no location specified)
Oct 8, 2022
Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)
Not yet recruiting
- Tuberculosis, Pulmonary
- HIV
- Bedaquiline
- +6 more
-
Port-au-Prince, Haiti
- +1 more
Nov 11, 2022
Tuberculosis, Pulmonary Trial in Observatory (Atorvastatin 40mg, Placebo oral tablet)
Recruiting
- Tuberculosis, Pulmonary
- Atorvastatin 40mg
- Placebo oral tablet
-
Observatory, WC, South AfricaGeneral Medicine & Global Health, Cape Heart Institute, Faculty
Oct 13, 2022
HIV, Tuberculosis, Smoking Cessation Trial in Rondebosch (QUIT-AD, Enhanced Treatment as Usual)
Not yet recruiting
- HIV Infections
- +2 more
- QUIT-AD
- Enhanced Treatment as Usual
-
Rondebosch, South AfricaUniversity of Cape Town
Apr 24, 2023
Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)
Recruiting
- Tuberculosis, Multidrug-Resistant
- Delamanid
- +4 more
-
Dasmariñas, Philippines
- +1 more
Jun 21, 2022
Tuberculosis, Alcohol Consumption, Treatment Adverse Effect Trial in Worcester (DOT Adherence Monitoring)
Active, not recruiting
- Tuberculosis
- +2 more
- DOT Adherence Monitoring
-
Worcester, Western Cape Province, South AfricaWorcester Community Day Centre
Jun 28, 2022
Tuberculosis Trial in Kota Kinabalu (Mobile Application, Direct Observed Therapy)
Not yet recruiting
- Tuberculosis
- Mobile Application
- Direct Observed Therapy
-
Kota Kinabalu, Sabah, MalaysiaMohd Fazeli bin Sazali
May 20, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,
Completed
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +5 more
-
Rio de Janeiro, Brazil
- +25 more
Jun 23, 2022
Diagnostics and Pharmacotherapy for Severe Forms of TB
Completed
- Tuberculosis
- (no location specified)
Mar 8, 2022
Unusual Infiltrative Patterns of Malignant Cells in Endometrial
Not yet recruiting
- Endometrial Cancer
- (no location specified)
Mar 11, 2023
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
Recruiting
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
-
Milan, ItalyOspedale San Raffaele
Aug 29, 2023
Pre-XDR-TB Trial in Seoul (BPaL regimen)
Not yet recruiting
- Pre-XDR-TB
- BPaL regimen
-
Seoul, Songpa-gu, Korea, Republic ofAsan Medical Center
Jul 19, 2022
Tuberculosis, MDR Trial in Kazakhstan, Kyrgyzstan (FS-1, Placebo)
Completed
- Tuberculosis, MDR
- FS-1
- Placebo
-
Semey, East-Kazakhstan Region, Kazakhstan
- +5 more
May 17, 2022
Four Months Moxifloxacin Containing Daily Regimen Study Among
Not yet recruiting
- Tuberculosis, Pulmonary
- Isoniazid
- +4 more
-
Chennai, Tamilnadu, IndiaNational Institute for Research in Tuberculosis
Sep 29, 2021
Tuberculosis Trial in Shanghai, Hangzhou (Short-course regimen, Standard regimen)
Active, not recruiting
- Tuberculosis
- Short-course regimen
- Standard regimen
-
Shanghai, Shanghai, China
- +1 more
Nov 22, 2023
HIV/TB Coinfection Trial in Thailand (DTG 50 mg OD with food, DTG 50 mg BID)
Recruiting
- HIV/TB Coinfection
- DTG 50 mg OD with food
- DTG 50 mg BID
-
Chiang Rai, Chiangrai, Thailand
- +9 more
Mar 22, 2022
Evaluation in Children and Adults
Recruiting
- Tuberculosis
- urine colorimetric assay
-
Newark, New Jersey
- +1 more
Mar 8, 2022
Opioid Dependence, Addiction, HIV/AIDS Trial in Kajang (Buprenorphine Naloxone, Methadone, Isoniazid)
Recruiting
- Opioid Dependence
- +4 more
- Buprenorphine Naloxone
- +3 more
-
Kajang, Selangor, MalaysiaKajang Prison
May 18, 2022
Tuberculosis, Pulmonary Trial in South Africa, Tanzania (H56:IC31, Placebo)
Recruiting
- Tuberculosis, Pulmonary
- H56:IC31
- Placebo
-
Bellville, Cape Town, South Africa
- +5 more
Sep 27, 2021
MDR-TB Trial in Shanghai (PRS Regimen V, MDR-TB Treatment Regimen(WHO))
Recruiting
- MDR-TB
- PRS Regimen V
- MDR-TB Treatment Regimen(WHO)
-
Shanghai, ChinaShanghai Pulmonary Hospital
Aug 4, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,
Active, not recruiting
- Tuberculosis, Pulmonary
- +5 more
- Pretomanid
- +3 more
-
Tbilisi, Georgia
- +10 more
Jan 26, 2022